Trial Profile
A Phase 2 Clinical Trial of TXA302 in Stroke Recovery
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs TXA-302 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Constant Therapeutics
- 09 Mar 2018 New trial record
- 06 Mar 2018 According to a Constant Pharmaceuticals media release, the company expects to initiate this trial in early 2019.